Skip to product information
1 of 1

ADRP/Perilipin-2 Recombinant Rabbit mAb (S-2210-3)

ADRP/Perilipin-2 Recombinant Rabbit mAb (S-2210-3)

Catalog Number: S0B6128 Application: WB,ICC Reactivity: Human,Mouse Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen ADRP/Perilipin-2
Synonyms Perilipin-2; Adipophilin; Adipose differentiation-related protein (ADRP); ADFP; PLIN2
Immunogen Synthetic Peptide
Location Membrane
Accession Q99541
Clone Number S-2210-3
Antibody Type Recombinant mAb
Isotype IgG
Application WB, ICC
Reactivity Hu, Ms
Positive Sample HepG2, 293T, K562, NIH/3T3, mouse liver
Predicted Reactivity Bv, Pg
Purification Protein A
Concentration 0.5 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:1000-1:2000 Hu, Ms
ICC 1:500 Hu

Background

Adipose Differentiation-Related Protein (ADRP), also known as Perilipin-2 or ADFP, is a 49 kDa lipid droplet surface protein belonging to the PAT family (which includes Perilipin, ADRP, TIP47, S3-12, and OXPAT). It plays a crucial role in lipid droplet formation, stabilization, and metabolic regulation. ADRP is expressed in various cell types, such as hepatic stellate cells, adipocytes, and macrophages, where it modulates lipid storage and release. Studies show that ADRP promotes intracellular lipid accumulation by inhibiting ATGL (adipose triglyceride lipase)-mediated lipolysis while enhancing exogenous fatty acid uptake, thereby influencing lipid droplet size and secretion. Additionally, dysregulated ADRP expression is associated with pathological conditions, including atherosclerosis, non-alcoholic fatty liver disease (NAFLD), and certain cancers. For example, ADRP is highly expressed in foam cells of atherosclerotic plaques, promoting cholesterol ester accumulation, whereas its expression is reduced in the livers of type 2 diabetic patients with fatty liver disease.

Picture

Western Blot

WB result of ADRP/Perilipin-2 Recombinant Rabbit mAb
Primary antibody: ADRP/Perilipin-2 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: HeLa whole cell lysate 20 µg
Lane 2: HepG2 whole cell lysate 20 µg
Lane 3: 293T whole cell lysate 20 µg
Lane 4: K562 whole cell lysate 20 µg
Low expression control: HeLa whole cell lysate
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 48 kDa
Observed MW: 48 kDa

WB result of ADRP/Perilipin-2 Recombinant Rabbit mAb
Primary antibody: ADRP/Perilipin-2 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: NIH/3T3 whole cell lysate 20 µg
Lane 2: mouse liver lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 48 kDa
Observed MW: 48 kDa

Immunocytochemistry

ICC shows positive staining in HepG2 cells. Anti-ADRP antibody was used at 1/500 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 100% ice-cold methanol and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)